These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 462852)

  • 61. Radiation response of "clonogenic" tumor cell release from NFSA2ALM1 tumors.
    Suzuki N
    Radiat Res; 1984 Jun; 98(3):649-55. PubMed ID: 6729057
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Drug sensitivity of methylnitrosourea- and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea-resistant L1210 lines.
    Schmid FA; Otter GM; Chen CF
    Cancer Res; 1986 Sep; 46(9):4469-71. PubMed ID: 3731103
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Synergistic antitumor activity of cisplatin and interleukin 1 in sensitive and resistant solid tumors.
    Braunschweiger PG; Basrur VS; Santos O; Markoe AM; Houdek PV; Schwade JG
    Cancer Res; 1993 Mar; 53(5):1091-7. PubMed ID: 8439953
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Establishment and biological properties of a guinea pig colonic adenocarcinoma cell line induced by N-methyl-N-nitrosourea.
    O'Donnell RW; Cockerell GL
    Cancer Res; 1981 Jun; 41(6):2372-7. PubMed ID: 7237435
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vitro versus in vivo correlations of chemosensitivity of human medulloblastoma.
    Friedman HS; Schold SC; Muhlbaier LH; Bjornsson TD; Bigner DD
    Cancer Res; 1984 Nov; 44(11):5145-9. PubMed ID: 6488174
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of feeder cell-released substances on the survival of clonogenic 9L cells after treatment with antimetabolites.
    Weizsaecker M; Deen DF
    Cancer Res; 1980 Sep; 40(9):3202-5. PubMed ID: 7000339
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Effect of N-nitroso-N-methylurea on DNA and RNA synthesis in cells of liver and spleen tumors in leucosis L-1210].
    Sokolova IS; Ostrovskaia LA; Bunto TV; Gorbacheva LB
    Vopr Onkol; 1976; 22(10):61-6. PubMed ID: 1014495
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Role of murine tumor models in cancer treatment research.
    Martin DS; Balis ME; Fisher B; Frei E; Freireich EJ; Heppner GH; Holland JF; Houghton JA; Houghton PJ; Johnson RK
    Cancer Res; 1986 Apr; 46(4 Pt 2):2189-92. PubMed ID: 3948188
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Metabolic activation of N-methyl-N-nitrosourea in tumor cells].
    Abakumova OIu; Kutsenko NG
    Vopr Med Khim; 1981; 27(3):383-7. PubMed ID: 7281582
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The combination of methyl-CCNU and irradiation: cell survival studies on a human tumor xenograft.
    Bateman AE; Fu KK; Towse GD
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1545-8. PubMed ID: 536260
    [No Abstract]   [Full Text] [Related]  

  • 71. Combination chemotherapy with 1-methyl-1-nitrosourea (MNU) and cyclophosphamide in solid tumors.
    Kolarić K
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1977 Aug; 89(3):311-9. PubMed ID: 143813
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Combination chemotherapy with 1-methyl-1-nitrosourea and cyclophosphamide in metastatic melanoma.
    Kolarić K; Roth A; Fuss V
    Tumori; 1978 Feb; 64(1):89-94. PubMed ID: 653833
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [A comparative study of the action of 1-methyl-1-nitrosourea and 1,3-dimethyl-1-nitrosourea on tumor cell DNA in vitro and in vivo by the alkaline elution method].
    Bliukhterova NV; Smotriaeva MA; Krugliakova KE
    Izv Akad Nauk Ser Biol; 1996; (3):276-81. PubMed ID: 8755027
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of chemotherapeutic agents in a new murine renal carcinoma model.
    Hrushesky WJ; Murphy GP
    J Natl Cancer Inst; 1974 Apr; 52(4):1117-22. PubMed ID: 4826582
    [No Abstract]   [Full Text] [Related]  

  • 75. Treatment of metastatic brain tumors with the combination of 1-methyl-1-nitrosourea (MNU) and cyclophosphamide.
    Kolarić K; Roth A
    J Cancer Res Clin Oncol; 1980; 97(2):193-8. PubMed ID: 7462297
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Development of an in vitro colony formation assay for the evaluation of in vivo chemotherapy of a rat brain tumor.
    Rosenblum ML; Knebel KD; Wheeler KT; Barker M; Wilson CB
    In Vitro; 1975; 11(5):264-73. PubMed ID: 1184035
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Survival of clonogenic cells of a murine epithelioma treated with neocarzinostatin.
    Sakamoto K; Sakka M
    Eur J Cancer (1965); 1973; 9(11-12):829-31. PubMed ID: 4804309
    [No Abstract]   [Full Text] [Related]  

  • 78. Clonogenic assays in the B16 melanoma: response to cyclophosphamide.
    Steel GG; Adams K; Stephens TC
    Br J Cancer; 1977 Nov; 36(5):618-24. PubMed ID: 588423
    [TBL] [Abstract][Full Text] [Related]  

  • 79. An artefact in clonogenic assays of bleomycin cytotoxicity.
    Twentyman PR
    Br J Cancer; 1977 Nov; 36(5):642-4. PubMed ID: 73379
    [No Abstract]   [Full Text] [Related]  

  • 80. Timing of assays: an important consideration in the determination of clonogenic cell survival both in vitro and in vivo.
    Twentyman PR
    Int J Radiat Oncol Biol Phys; 1979 Aug; 5(8):1213-20. PubMed ID: 528265
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.